Health Care & Life Sciences » Pharmaceuticals | Genomma Lab Internacional S.A.B.

Genomma Lab Internacional S.A.B. de C.V. | Mutual Funds

Mutual Funds that own Genomma Lab Internacional S.A.B. de C.V.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
American Funds Small Cap World Fund
55,153,000
5.26%
-12,330,000
0.13%
06/30/2018
American Funds New World Fund
41,949,334
4%
0
0.11%
06/30/2018
Fidelity Latin America Fund
19,735,269
1.88%
219,890
3.69%
07/31/2018
Fidelity International Small Cap Fund
13,101,700
1.25%
2,007,700
0.56%
04/30/2018
Vanguard Emerging Markets Stock Index Fund
12,914,569
1.23%
-140,000
0.01%
07/31/2018
Vanguard Total International Stock Index Fund
10,635,939
1.01%
0
0%
07/31/2018
MFS Emerging Markets Equity Fund
10,331,723
0.99%
6,107
0.56%
07/31/2018
MFS International New Discovery Fund
8,460,970
0.81%
0
0.11%
07/31/2018
DFA Emerging Markets Core Equity Portfolio
8,039,900
0.77%
-242,158
0.03%
04/30/2018
MFS New Discovery Value Fund
7,812,072
0.75%
0
0.41%
07/31/2018

About Genomma Lab Internacional

View Profile
Address
Antonio Dovalí Jaime, 70, Piso 2
Mexico City Distrito Federal 01210
Mexico
Employees -
Website http://www.genommalab.com
Updated 07/08/2019
Genomma Lab Internacional SAB de CV engages in the development, manufacturing and marketing of pharmaceutical, beauty and personal care products. The company was founded on October 30, 1996 and is headquartered in México City, Mexico. .